CS Paper Radar

Optimal chemo-immunotherapy scheduling: A hybrid QPSO-SQP approach with Michaelis-Menten pharmacodynamics

Bereket Sitotaw Kidane, Md Samiul Haque Motayed, Shuo Wang

eess.SY math.OC ·submitted 2026-09-10 08:16 UTC · v1
publishedtheory

Abstract

Optimal scheduling of combined chemo-immunotherapy is often formulated as a control-affine optimal control problem, which generically yields boundary-selected (bang-bang-type) protocols unless singular arcs occur. This structure, while convenient, neglects saturating pharmacodynamics at high dose rates. We incorporate Michaelis-Menten saturation directly into the therapy channels, making the dynamics non-control-affine and the Hamiltonian nonlinear in each control. With strictly positive exposure penalties, the Hamiltonian admits an explicit three-regime pointwise minimization law: each input is chosen at the lower bound, the upper bound, or as a unique interior minimizer. On interior intervals the strict Legendre condition holds, so continuously modulated dosing arises as a regular interior extremal rather than a singular-arc or smoothing artifact. The resulting transcription is nonconvex; we therefore use a hybrid Quantum Particle Swarm Optimization (QPSO)-Sequential Quadratic Programming (SQP) pipeline, where QPSO provides a constraint-aware warm start and SQP enforces feasibility and Karush-Kuhn-Tucker (KKT) optimality on a collocation grid. Costate reconstruction corroborates the Pontryagin Minimum Principle (PMP) structure and the predicted boundary/interior regime transitions.

Comment
23 pages, 6 figures, 3 tables. Published in Discrete and Continuous Dynamical Systems - Series B
Journal ref
Discrete and Continuous Dynamical Systems - Series B, 38 (2026), 280-302
DOI
10.3934/dcdsb.2026072

Closest papers

Nearest neighbours by meaning across the whole index.

Optimal Control for Cancer Chemotherapy Using Hybrid Quantum Particle Swarm Optimization

eess.SY math.OC ·2026-09-10 ·Bereket Sitotaw Kidane, Md Samiul Haque Motayed, Shuo Wang
published similarity 0.68
Abstract · 6 pages, 6 figures. Published in the 2025 IEEE 64th Conference on Decision and Control (CDC)

Optimal control in cancer chemotherapy is challenged by tumor heterogeneity and mutations, which complicate treatment effectiveness. Traditional methods, such as Pontryagin's maximum principle (PMP), are often hindered by their reliance on an initial guess for the costate equation, affecting accuracy and convergence. To address these limitations, this work introduces a hybrid quantum particle swarm optimization (QPSO) method based on regularization. QPSO is employed for global exploration to approximate the optimal control trajectory, followed by a regularization-based refinement to ensure smoothness and consistency with optimality conditions. The Hamiltonian function is used for first- and second-order optimality checks, verifying solution quality. Numerical case studies explore various drug effectiveness functions, demonstrating the role of periodic and localized drug delivery in achieving robust tumor suppression and providing insights into the impact of different drug combinations on optimal chemotherapy strategies.

0.75

Behavioral Cloning Outperforms Entropy-Regularized RL: Critic-Driven Failure of Actor-Critic Methods on Adaptive Tumor Treatment

cs.LG ·2026-09-06 ·Aleksandar Dimitrov, Giacomo Spigler
similarity 0.53
Abstract · 9 pages, 3 figures

Adaptive dosing requires policies that reduce tumor burden without excessive toxicity. Learned dosing policies are typically judged against historical or heuristic comparators, which cannot show whether a policy has found the best behavior available. We instead study a three-population tumor-control ODE in which optimal-control analysis fixes the form of a good schedule -- bang-bang dosing punctuated by a singular arc -- and construct a numerical controller of that form as a proxy for near-optimal behavior. Judged against this reference under a sustained-cure criterion -- 200 consecutive days below 5% carrying capacity -- Soft Actor-Critic (SAC) trained from scratch never reaches cure. Behavioral cloning (BC) of the reference reproduces it (100% sustained cure, 30/30 seeds), but SAC fine-tuning of the cloned policy destroys it across five entropy coefficients, and TD3 and BC-regularized SAC fail identically; the pattern persists under multiplicative pharmacokinetic action noise. Along curative trajectories the post-collapse critic ranks the collapsed-policy action above the reference action in 96% of states, concentrated in the maintenance phase, and the policy settles into a non-curative adaptive-therapy equilibrium. The reference is what makes this legible: against a heuristic comparator the fine-tuned policy would read as a competent controller rather than a failure.

0.29

Adaptive Chemotherapy Control under Tumor Heterogeneity via Reinforcement Learning

cs.LG eess.SY ·2026-09-10 ·Bereket Sitotaw Kidane, Md Samiul Haque Motayed, Shuo Wang
publishedbenchmark similarity 0.53
Abstract · 6 pages. Published in the 2026 American Control Conference (ACC)

Designing effective chemotherapy regimens is hindered by tumor heterogeneity and drug resistance, which complicate the deployment of patient-specific model-based optimal control across diverse populations. We develop and compare closed-loop deep reinforcement learning (DRL) dosing policies with continuous (TD3) and discrete (DQN) action spaces trained on a high-dimensional heterogeneous tumor model. The DRL policies are benchmarked against a Pontryagin's Maximum Principle (PMP)-derived open-loop benchmark. We assess generalization under parametric heterogeneity using a 100-patient virtual cohort with plus or minus 10 percent uniform perturbations in growth and drug-sensitivity parameters. Across this cohort, TD3 achieves higher average tumor reduction, while DQN yields tighter inter-patient dosing consistency, revealing a clear efficacy-consistency trade-off in this study. Our simulations assume full observation of all tumor subpopulations; translation to sparse and noisy clinical measurements will require partial-observability formulations and/or state estimation. Overall, the results show that simulation-trained DRL can learn state-dependent feedback dosing policies that complement open-loop optimal control benchmarks.

0.33

Dynamical Unbalanced Optimal Transport: Duality, Reachability, and Computation

eess.SY math.OC ·2026-11-02 ·Dongjun Wu, Anders Rantzer
similarity 0.52
Abstract

We study dynamical unbalanced optimal transport for nonlinear control-affine systems in which the control input affects both the transportation of mass and its growth or decay. This phenomenon arises naturally in controlled transport-reaction systems such as cancer treatment, and distinguishes the problem from standard unbalanced optimal transport, where transport and mass variation are typically independent. To address this problem, we combine classical relaxed-control theory with a weighted superposition principle to obtain an infinite-dimensional linear programming reformulation over weighted trajectories. Under suitable convexity and compactness assumptions, we show that this relaxation is tight. Based on the relaxation, we derive a Kantorovich dual formulation in terms of Hamilton-Jacobi-Bellman inequalities, and establish strong duality over smooth subsolutions. We then utilize the dual formulation to characterize reachability of the system, namely, when a given terminal measure is reachable from a given initial measure. In addition, tractable sufficient conditions for reachability are provided. Finally, we develop an augmented-Lagrangian algorithm based on the dual formulation for numerical computation of the optimal transport plan. The framework is illustrated on a phenotype-structured cancer treatment problem in which therapy simultaneously drives phenotypic adaptation and population growth or death.

0.23

Optimization Geometry of QAOA and Variational Quantum Algorithms

cs.NE quant-ph ·2026-10-04 ·Vojtěch Novák, Ivan Zelinka, Silvie Illésová, Swagatam Das, Martin Beseda
similarity 0.51
Abstract

Variational quantum algorithms turn choices of Hamiltonian, ansatz, and parameterization into a classical nonconvex optimization problem. We study how this objective function can be visualized and characterized in ways that help explain optimizer behavior. We distinguish two properties of the objective: the number of local minima encountered along sampled directions and the differences in quality among local-search endpoints. We then ask how a local optimizer, represented by BFGS, compares with adaptive differential evolution, represented by jSO. Rather than comparing jSO with a single local run, we allow BFGS multiple starts within the same function-evaluation budget. This gives local search repeated opportunities to explore different basins and provides a stronger baseline for asking when a global evolutionary solver is useful. We study these questions using VQE and QAOA, focusing on how frustra- tion, circuit depth, parameter tying, mixed locality, and nonlinear repa- rameterization change the Hamiltonian expectation-value objective seen by the classical optimizer. Increasing independent circuit depth raises the sampled local-minimum count without making global search more effective. Parameter tying, by contrast, produces both more repeated local structure and much larger differences in quality among local-search endpoints, and in this regime adaptive differential evolution outperforms function-evaluation-matched multistart BFGS. The comparison shows that the number of local minima alone does not determine whether global search is advantageous: the important distinction is whether different basins lead to similarly good solutions or to substantially different objective values. These results provide a practical workflow for connecting model construction, objective- function geometry, empirical diagnostics, and optimizer choice.

0.08

Feasibility and optimum recovery in warm-start quantum optimization for a drug-response model on a trapped-ion processor

cs.ET quant-ph ·2026-09-19 ·Tanzir Hossain, Rajib Rana, Prabal Datta Barua, Abu Ali Ibn Sina, Niall Higgins +3 more
similarity 0.50
Abstract

On a seven-compound drug-response model, warm-start quantum approximate optimization (QAOA) on IonQ Forte-1 returned valid assignments more often than random bitstrings, but this alone did not show effective optimization. Ideal QAOA raised optimum probability above uniform feasible sampling in only four of twelve reference circuits. Hardware often fell below its own noiseless circuits, while greedy search solved all hardware models within 200 objective evaluations. Expanded simulations showed a gain over feasible sampling in 28 of 35 CAMA-1 panels and none of four 647-V panels. Annealing solved all these panels in every seed. A Grover mixer preserved feasibility and improved optimum probability over feasible sampling in all ten tested models. We analyzed 25 completed tasks containing 5,300 shots from 18 circuits and 14 instances. The encodings use 6-35 qubits and at most 4,900 feasible assignments, which we enumerated to establish exact optima. Noiseless references now cover both the original six circuits and six wider circuits. At 35 qubits, with 4,900 feasible assignments, ideal feasibility was 35.85%, compared with 7 of 200 valid hardware outputs. Its ideal optimum probability was below both sampling controls. The circuits sample assignments in a model built from measured single-agent and pairwise responses.

0.32

pCoMole: Pareto-Constrained Molecule Editing with Discrete Flows

cs.LG q-bio.BM ·2026-10-01 ·Tong Chen, Maximilian Holsman, Lin Zhao, Pranam Chatterjee
top venue similarity 0.50
Abstract · Published at NeurIPS 2026. (Proceedings of the 40th Conference on Neural Information Processing Systems, Sydney, Australia)

Biomolecular therapeutics often start from known sequences and require targeted editing to improve multiple properties while satisfying hard biochemical and manufacturability constraints. However, existing generative methods do not jointly support multi-objective optimization, hard feasibility, and sequence editing in discrete, variable-length biological spaces. In this work, we introduce Pareto-Constrained Molecule Editing (pCoMole), a framework built on discrete flow matching that steers a pre-trained Edit Flow toward user-specified preferences while enforcing terminal feasibility. pCoMole defines a feasibility-gated terminal distribution using an augmented Tchebycheff utility and realizes the resulting preference tilt through a Doob-h transform of the underlying edit process. To make this construction practical, we approximate the required harmonic function using short Monte Carlo rollouts over candidate edits, yielding an efficient guided editor with provable preference consistency. We validate pCoMole by shrinking GFP while retaining fluorescence-related properties, shortening diverse Cas9 orthologs while preserving PAM specificity, and compressing peptide binders into short peptidomimetics that optimize seven drug-related properties under hard constraints. In wet lab testing, two 229-residue pCoMole-designed eGFP variants retained clear green fluorescence in BL21 cells after 10 deletions, with either one or two substitutions. Together, pCoMole enables constraint-aware, Pareto-aligned editing of biomolecular sequences in discrete, variable-length spaces.

0.36

Conditions for Global Optimality in Quantum Arimoto-Blahut Algorithms

cs.IT math.OCquant-ph ·2026-09-09 ·Geng Liu, Masahito Hayashi
similarity 0.50
Abstract

Generalized Arimoto--Blahut (AB) algorithms are widely used in information theory and quantum optimization, but monotonic objective decrease and numerical stabilization do not guarantee global optimality. We establish necessary and sufficient conditions for the global optimality of full-rank AB fixed points for convex differentiable objectives under linear constraints. An AB fixed point is globally optimal if and only if the AB update direction and the objective gradient differ by an element of the constraint normal space at that point. The same compatibility condition characterizes agreement between individual AB and mirror-descent (MD) updates, whereas pathwise equivalence requires it along the entire common trajectory. Thus, an AB algorithm may follow a trajectory different from MD and still reach the global optimum. We also develop a posteriori optimality certificates based on feasible directional derivatives, including finite-difference upper bounds on the objective gap that require only objective evaluations. For channel relative entropy between dephasing and depolarizing channels, we analytically identify the global minimizer as the unique full-rank AB fixed point, although pathwise equivalence fails. Numerical experiments illustrate convergence of AB and MD along different trajectories and validate the certificates. By contrast, an amplitude-damping example shows that a monotone AB iteration can stabilize at a suboptimal fixed point, whose nonoptimality is detected by the finite-difference certificate. These results provide structural and computable criteria for assessing global optimality in quantum AB algorithms.

0.21